Clinical Trial Supply Trends & Predictions Industry Report 2013

We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

What are your priorities for your clinical trial supply in 2013?
Download this report and discover how to:
  • Reduce overage through implementing product pooling and just in time labelling with strategies from our expert advisory panel
  • Leverage outsourcing opportunities by learning best practice in distribution and logistics
  • Get to grips with GDP regulations to understand the latest requirements for controlled room temperature

4 Key findings from the report include

  • Supporting numerous clinical trials is the main priority for respondents for the next 5 years
  • 42% run between 1 and 10 active trials annually
  • 71% predict the number of trials in BRIC countries to increase in the next 12 mont
  • China was selected as the most likely popular destination for clinical trials in the next 5 years at 35.4%
Have Your Say
Rate this feature and give us your feedback in the comments section below